Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Justin J. Montoya"'
Autor:
Justin J. Montoya, Megan A. Turnidge, Daniel H. Wai, Apurvi R. Patel, David W. Lee, Vijay Gokhale, Laurence H. Hurley, Robert J. Arceci, Cynthia Wetmore, David O. Azorsa
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Acute Myeloid Leukemia (AML) is a malignancy of myeloid precursor cells that arise from genomic alterations in the expression of key growth regulatory genes causing cells to assume an undifferentiated state and continue to prolife
Externí odkaz:
https://doaj.org/article/70b17a3e059a4dbc847f00fba0fb5ba6
Autor:
Vijay Gokhale, Robert J. Arceci, David W. Lee, Laurence H. Hurley, Megan A. Turnidge, Justin J. Montoya, Daniel H. Wai, Apurvi R. Patel, David O. Azorsa, Cynthia Wetmore
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
Background Acute Myeloid Leukemia (AML) is a malignancy of myeloid precursor cells that arise from genomic alterations in the expression of key growth regulatory genes causing cells to assume an undifferentiated state and continue to proliferate. Rec
Publikováno v:
Annals of Oncology. 30:vii20-vii21
Background The five-year-survival-rate for paediatric patients with Acute Myeloid Leukaemia (AML) is from 60-70%. The most common causes of death are disease relapse and chemo-resistance. Typically, drug dose response testing is performed at atmosphe
Autor:
Justin J. Montoya, Megan A. Turnidge, Daniel H. Wai, David W. Lee, Apruvi Patel, Vijay Gokhale, Laurence J. Hurley, David O. Azorsa
Publikováno v:
Cancer Research. 79:2967-2967
Acute Myeloid Leukemia (AML) is a malignancy of myeloid precursor cells that can occur when genomic changes alter expression of key genes, causing cells to resume an undifferentiated state and proliferate. Ongoing efforts have focused on developing t
Autor:
Justin J, Montoya, David O, Azorsa
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1470
RNAi screening of mammalian cells is often performed using siRNAs and cationic lipids as transfection reagents. Efficiency of transfection depends on growth characteristics of the cells and the cationic lipid used. With a large selection of cationic
Autor:
Vijay Gokhale, Daniel H. Wai, David W. Lee, Laurence H. Hurley, Justin J. Montoya, David O. Azorsa, Robert J. Arceci, Apurvi Patel, Megan A. Turnidge
Publikováno v:
Cancer Research. 78:B04-B04
Acute myeloid leukemia (AML) is a disease that can affect both children and adults and is characterized by complex and heterogeneous genomic changes, including MYC overexpression driven in part by the bromodomain (BRD) and extraterminal (BET) protein
Publikováno v:
Cancer Research. 77:2349-2349
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and young adults. The five-year survival rate for RMS has hardly improved over the last three decades despite intensive and toxic chemotherapy, radiotherapy with surgery. There
Autor:
David W. Lee, Justin J. Montoya, Daniel H. Wai, David O. Azorsa, Robert J. Arceci, Apurvi Patel
Publikováno v:
Cancer Research. 77:4077-4077
Patients with Down’s syndrome who develop acute myeloid leukemia (AML) are at increased risk of toxicity secondary to chemotherapy regimens. These patients are harder to treat with conventional therapies at relapse. Overall, the use of targeted dru
Autor:
David O. Azorsa, Justin J. Montoya, Daniel H. Wai, Robert J. Arceci, David W. Lee, Oliver B. Pepper, Peter Azorsa
Publikováno v:
Cancer Research. 77:3338-3338
Ewing sarcoma is the second most common cancer of bone and soft tissue arising in children and young adults. Although the survival rate has improved for patients treated for localized disease, the survival rate for patients with metastatic tumor rema
Abstract 5181: Targeted knockdown of MYC in AML cells using G-quadruplex interacting small molecules
Autor:
Vijay Gokhale, Robert J. Arceci, Megan A. Turnidge, Laurence H. Hurley, David O. Azorsa, Justin J. Montoya, Daniel H. Wai, David W. Lee, Apurvi R. Patel
Publikováno v:
Cancer Research. 77:5181-5181
Acute Myeloid Leukemia (AML) is a disease that occurs when genomic changes alter expression of key genes, causing cells to resume an undifferentiated state, proliferate, and maintain tumor growth throughout the body. Recently, there has been an incre